FDA
-
-
-
-
-
-
-
Pear Therapeutics (PEAR) Announces Inclusion of reSET and reSET-O on the January 2023 Florida Medicaid Preferred Drug List
-
-
-
-
-
-
-
Pear Therapeutics Reports Third Quarter 2022 Results
-
-
-
-
-
-
-
Pear Therapeutics Announces Publication of Real-World Data Showing High Rates of Engagement, Retention and Abstinence with reSET®
-
-
-
-
-
-
-
Pear Therapeutics (PEAR), SelectHealth Announce Coverage to Provide Access to FDA-Authorized Prescription Digital Therapeutic for the Treatment of Opioid Use Disorder
-
-
-
-
-
-
-
Pear Therapeutics Announces Three New Board Members
-
-
-
-
-
-
-
Pear Therapeutics to Participate in the Jefferies Healthcare Conference
-
-
-
-
-
-
-
Pear Therapeutics to Participate in the Bank of America 2022 Healthcare Conference
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

